Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is N/A as of Tuesday, October 6, 2026.
ENTERPRISE VALUE (EV)
N/A
Braveheart Bio, Inc.
Market Cap
$1.49B
Enterprise Value (EV)
N/A
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.49B | N/A |
| Certara, Inc. (CERT)vs › | $1.49B | $1.60B |
| GH Research PLC (GHRS)vs › | $1.50B | $1.15B |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.47B | $1.33B |
| Phibro Animal Health Corporation (PAHC)vs › | $1.51B | $2.24B |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | $1.32B |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | $1.52B |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | $1.57B |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.43B | $1.31B |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | $1.68B |
Market Cap
$1.49B
Total Debt
N/A
Cash
N/A
Enterprise Value
N/A
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
